Should Prostate Specific Antigen be Adjusted for Body Mass Index? Data From the Baltimore Longitudinal Study of Aging

Stacy Loeb, H. Ballentine Carter, Edward M. Schaeffer, Luigi Ferrucci, Anna Kettermann, E. Metter

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Purpose: Obesity may be associated with lower prostate specific antigen through hemodilution. We examined the relationship between body mass index and prostate specific antigen by age in men without prostate cancer in a longitudinal aging study to determine whether prostate specific antigen must be adjusted for body mass index. Materials and Methods: The study population included 994 men (4,937 observations) without prostate cancer in the Baltimore Longitudinal Study of Aging. Mixed effects models were used to examine the relationship between prostate specific antigen and body mass index in kg/m2 by age. Separate models were explored in men with prostate cancer censored at diagnosis, for percent body fat measurements, for weight changes with time and adjusting for initial prostate size in 483 men (2,523 observations) with pelvic magnetic resonance imaging measurements. Results: In men without prostate cancer body mass index was not significantly associated with prostate specific antigen after adjusting for age (p = 0.06). A 10-point body mass index increase was associated with a prostate specific antigen difference of -0.03 ng/ml (95% CI -0.40-0.49). Results were similar when men with prostate cancer were included, when percent body fat was substituted for body mass index, and after adjusting for prostate volume. Longitudinal weight changes also had no significant association with prostate specific antigen. Conclusions: Consistent with prior studies, we found an inverse relationship between obesity and serum prostate specific antigen. However, the magnitude of the difference was small. Thus, adjusting prostate specific antigen for body mass index does not appear warranted.

Original languageEnglish (US)
Pages (from-to)2646-2652
Number of pages7
JournalJournal of Urology
Volume182
Issue number6
DOIs
StatePublished - Dec 1 2009
Externally publishedYes

Fingerprint

Baltimore
Prostate-Specific Antigen
Longitudinal Studies
Body Mass Index
Prostatic Neoplasms
Adipose Tissue
Prostate
Obesity
Weights and Measures
Hemodilution
Magnetic Resonance Imaging

All Science Journal Classification (ASJC) codes

  • Urology

Cite this

Should Prostate Specific Antigen be Adjusted for Body Mass Index? Data From the Baltimore Longitudinal Study of Aging. / Loeb, Stacy; Carter, H. Ballentine; Schaeffer, Edward M.; Ferrucci, Luigi; Kettermann, Anna; Metter, E.

In: Journal of Urology, Vol. 182, No. 6, 01.12.2009, p. 2646-2652.

Research output: Contribution to journalArticle

Loeb, Stacy ; Carter, H. Ballentine ; Schaeffer, Edward M. ; Ferrucci, Luigi ; Kettermann, Anna ; Metter, E. / Should Prostate Specific Antigen be Adjusted for Body Mass Index? Data From the Baltimore Longitudinal Study of Aging. In: Journal of Urology. 2009 ; Vol. 182, No. 6. pp. 2646-2652.
@article{dbe052f6b62a4eccaee6514cae94dcac,
title = "Should Prostate Specific Antigen be Adjusted for Body Mass Index? Data From the Baltimore Longitudinal Study of Aging",
abstract = "Purpose: Obesity may be associated with lower prostate specific antigen through hemodilution. We examined the relationship between body mass index and prostate specific antigen by age in men without prostate cancer in a longitudinal aging study to determine whether prostate specific antigen must be adjusted for body mass index. Materials and Methods: The study population included 994 men (4,937 observations) without prostate cancer in the Baltimore Longitudinal Study of Aging. Mixed effects models were used to examine the relationship between prostate specific antigen and body mass index in kg/m2 by age. Separate models were explored in men with prostate cancer censored at diagnosis, for percent body fat measurements, for weight changes with time and adjusting for initial prostate size in 483 men (2,523 observations) with pelvic magnetic resonance imaging measurements. Results: In men without prostate cancer body mass index was not significantly associated with prostate specific antigen after adjusting for age (p = 0.06). A 10-point body mass index increase was associated with a prostate specific antigen difference of -0.03 ng/ml (95{\%} CI -0.40-0.49). Results were similar when men with prostate cancer were included, when percent body fat was substituted for body mass index, and after adjusting for prostate volume. Longitudinal weight changes also had no significant association with prostate specific antigen. Conclusions: Consistent with prior studies, we found an inverse relationship between obesity and serum prostate specific antigen. However, the magnitude of the difference was small. Thus, adjusting prostate specific antigen for body mass index does not appear warranted.",
author = "Stacy Loeb and Carter, {H. Ballentine} and Schaeffer, {Edward M.} and Luigi Ferrucci and Anna Kettermann and E. Metter",
year = "2009",
month = "12",
day = "1",
doi = "10.1016/j.juro.2009.08.041",
language = "English (US)",
volume = "182",
pages = "2646--2652",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Should Prostate Specific Antigen be Adjusted for Body Mass Index? Data From the Baltimore Longitudinal Study of Aging

AU - Loeb, Stacy

AU - Carter, H. Ballentine

AU - Schaeffer, Edward M.

AU - Ferrucci, Luigi

AU - Kettermann, Anna

AU - Metter, E.

PY - 2009/12/1

Y1 - 2009/12/1

N2 - Purpose: Obesity may be associated with lower prostate specific antigen through hemodilution. We examined the relationship between body mass index and prostate specific antigen by age in men without prostate cancer in a longitudinal aging study to determine whether prostate specific antigen must be adjusted for body mass index. Materials and Methods: The study population included 994 men (4,937 observations) without prostate cancer in the Baltimore Longitudinal Study of Aging. Mixed effects models were used to examine the relationship between prostate specific antigen and body mass index in kg/m2 by age. Separate models were explored in men with prostate cancer censored at diagnosis, for percent body fat measurements, for weight changes with time and adjusting for initial prostate size in 483 men (2,523 observations) with pelvic magnetic resonance imaging measurements. Results: In men without prostate cancer body mass index was not significantly associated with prostate specific antigen after adjusting for age (p = 0.06). A 10-point body mass index increase was associated with a prostate specific antigen difference of -0.03 ng/ml (95% CI -0.40-0.49). Results were similar when men with prostate cancer were included, when percent body fat was substituted for body mass index, and after adjusting for prostate volume. Longitudinal weight changes also had no significant association with prostate specific antigen. Conclusions: Consistent with prior studies, we found an inverse relationship between obesity and serum prostate specific antigen. However, the magnitude of the difference was small. Thus, adjusting prostate specific antigen for body mass index does not appear warranted.

AB - Purpose: Obesity may be associated with lower prostate specific antigen through hemodilution. We examined the relationship between body mass index and prostate specific antigen by age in men without prostate cancer in a longitudinal aging study to determine whether prostate specific antigen must be adjusted for body mass index. Materials and Methods: The study population included 994 men (4,937 observations) without prostate cancer in the Baltimore Longitudinal Study of Aging. Mixed effects models were used to examine the relationship between prostate specific antigen and body mass index in kg/m2 by age. Separate models were explored in men with prostate cancer censored at diagnosis, for percent body fat measurements, for weight changes with time and adjusting for initial prostate size in 483 men (2,523 observations) with pelvic magnetic resonance imaging measurements. Results: In men without prostate cancer body mass index was not significantly associated with prostate specific antigen after adjusting for age (p = 0.06). A 10-point body mass index increase was associated with a prostate specific antigen difference of -0.03 ng/ml (95% CI -0.40-0.49). Results were similar when men with prostate cancer were included, when percent body fat was substituted for body mass index, and after adjusting for prostate volume. Longitudinal weight changes also had no significant association with prostate specific antigen. Conclusions: Consistent with prior studies, we found an inverse relationship between obesity and serum prostate specific antigen. However, the magnitude of the difference was small. Thus, adjusting prostate specific antigen for body mass index does not appear warranted.

UR - http://www.scopus.com/inward/record.url?scp=71849111494&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=71849111494&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2009.08.041

DO - 10.1016/j.juro.2009.08.041

M3 - Article

VL - 182

SP - 2646

EP - 2652

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 6

ER -